Cargando…
A Retrospective Analysis of 10 Years of Liver Surveillance Undertaken in Uveal Melanoma Patients Treated at the Supraregional “Liverpool Ocular Oncology Centre”, UK
SIMPLE SUMMARY: Around 45% of patients with uveal melanoma (UM) develop liver metastases on average 3 years after diagnosis of the primary tumour. After clinical detection of metastases, median patient survival is approximately one year. Early identification of metastases through liver surveillance...
Autores principales: | Rola, Alda Cunha, Kalirai, Helen, Taktak, Azzam F. G., Eleuteri, Antonio, Krishna, Yamini, Hussain, Rumana, Heimann, Heinrich, Coupland, Sarah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102800/ https://www.ncbi.nlm.nih.gov/pubmed/35565316 http://dx.doi.org/10.3390/cancers14092187 |
Ejemplares similares
-
Small High-Risk Uveal Melanomas Have a Lower Mortality Rate
por: Hussain, Rumana N., et al.
Publicado: (2021) -
Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study
por: Cunha Rola, Alda, et al.
Publicado: (2020) -
Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma
por: Robinson, Helena, et al.
Publicado: (2023) -
Parsimonious Models for Predicting Mortality from Choroidal Melanoma
por: Damato, Bertil, et al.
Publicado: (2020) -
Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
por: Farquhar, Neil, et al.
Publicado: (2017)